Please assess the completion status of the following clinical trial:

Trial Title: Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is Japanese.~* Smoking, healthy subject as judged by the Investigator.~* Subject smokes at least 10 commercially available mCCs per day (no brand restrictions) for the last 4 weeks, based on self-reporting.~* Subject has smoked for at least the last 3 consecutive years.~* Subject does not plan to quit smoking in the next 3 months.~Exclusion Criteria:~* As per Investigator judgment, the subject cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason).~* The subject has received medication within 14 days or within 5 half-lives of the medication (whichever is longer) which has an impact on cytochrome P450 1 A2 (CYP1A2) or cytochrome P450 2 A6 (CYP2A6) activity.~* For women: Subject is pregnant or is breast feeding.~* For women: Subject does not agree to use an acceptable method of effective contraception.

- Gender: ALL
- Minimum Age: 23 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- THS 2.2 Menthol (mTHS 2.2) (Type: EXPERIMENTAL): Ad libitum use of THS 2.2 Menthol for 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting
- Smoking abstinence (SA) (Type: ACTIVE_COMPARATOR): Abstinence from smoking for 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting
- Menthol Conventional Cigarette (mCC) (Type: ACTIVE_COMPARATOR): Ad libitum use of subject's own preferred brand of mCC for 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting

Based on this trial design, predict the completion outcome and termination type (if applicable).